AI-Powered Mental Health Care — Hybrid AI+Referral Model

Business Innovation Plan | Business Operations · Revenue Operations · Analytics

Safe and accessible early-stage mental health support through a hybrid AI-referral model.

TL;DR

Therapy access is broken for early-stage anxiety and depression: high cost, social stigma, and multi-month wait times keep people from getting help before symptoms escalate. This plan designs, validates, and operationalizes a hybrid AI + licensed-professional referral model — an AI chatbot handles early-stage, evidence-backed (CBT) conversational support, continuously monitors risk, and auto-escalates high-risk cases to a licensed professional within a <10 minute response window.

This README frames the plan the way a BizOps/RevOps/Analytics function would operationalize it: the problem, the model, the metrics that prove it works, the revenue engine, the risk register, and the systems stack that runs it day to day.

1. The Business Problem (Ops Lens)

Barriers and their operational consequences:

Cost of therapy — segments users out before they ever enter a funnel
Social stigma — depresses top-of-funnel demand generation
Long appointment wait times — creates a leaky, delayed conversion path between "need" and "care"

Target user: individuals with mild-to-moderate anxiety/depression symptoms who are not currently in therapy.

Core operating question: How do we build a scalable intake layer that gets people into some form of support immediately, without compromising safety, while creating a credible escalation path to licensed care when risk is detected?

2. Competitive Benchmarking (Market Ops)

BetterHelp — Low AI integration (human-led). Strength: credible, professional, curated care. Gap: doesn't scale; high cost; no real-time crisis handling.

Calm — Moderate AI integration (wellness). Strength: broad, accessible, low friction. Gap: not clinical; no crisis handling at all.

Woebot Health — High AI integration (AI-core). Strength: evidence-backed, scalable early intervention. Gap: keyword-based safety only; no human escalation loop.

Whitespace identified: no player combines AI scalability with a structured, time-bound human escalation layer. That gap is the product.

3. Idea Selection — NUF Scoring (Prioritization Framework)

Six concepts were scored on New / Useful / Feasible (out of 15):

Hybrid: AI + auto-referral for high-risk cases — NUF 13 — Selected
AI + human review of all sessions — NUF 11 — Lower scalability
AI mood-tracking with alerts — NUF 11 — Low clinical impact
Full-AI therapist — NUF 10 — Unregulatable, high liability
AI wellness program — NUF 10 — Low clinical impact
Peer-supported matching — NUF 10 — High liability, low structure

Positioning (Innovation Matrix): Existing Market x Existing Technology, which is Incremental Innovation. This is a deliberate ops decision — it de-risks regulatory exposure and shortens time-to-pilot versus a disruptive or architectural play.

4. Revenue Operations

Model: Freemium

Revenue streams:

Freemium subscription — free AI support tier; paid subscription for extended therapy programs
Referral revenue — revenue share with licensed therapy providers receiving escalations
B2B partnerships — employer HR/EAP programs, university partnerships, insurers

Why freemium, operationally: it lowers acquisition friction for the most hesitant segment (the whole point of the product), while the low/no-cost entry point also functions as a data acquisition engine — every free-tier interaction feeds the risk-detection model and product analytics.

Primary customer segments:

Entry market: university students (high stress, low income, high stigma sensitivity)
Expansion market: working professionals (moderate-to-high stress, need flexibility/immediacy)

Distribution channels: university counseling centers, campus partnerships, employer EAPs, digital health platform integrations.

5. Success Metrics and Analytics Framework
Two-week engagement rate — target 60% — proxy for early-stage adoption/retention
Escalation response time — target under 10 minutes — core safety SLA, the trust mechanism
Usability feedback — target over 60% positive — product-market fit signal from validation cohort

Validation method: 10 participants across 4 segments (students, professionals, prior-therapy, therapy-considered) completed prototype walkthroughs, scenario-based risk testing, and semi-structured interviews. Findings were coded thematically to extract cross-segment patterns in trust, safety expectations, and adoption barriers.

Key insight from validation (the analytics finding that reshaped the roadmap): trust-building features outperformed feature complexity. A visible "Safety Monitoring Active" indicator and a clear no-diagnosis disclaimer moved adoption more than any personalization feature would have. This directly informed MVP scope — advanced personalization and diagnosis features were deliberately excluded from v1 to reduce liability and safety risk during early-stage deployment.

6. Risk Register (Ops Governance)
Regulatory and liability (HIPAA/GDPR, misclassification) — mitigated by transparent escalation logic and documented, audited clinical validation
AI bias / misclassification — mitigated by broad, inclusive training data and ongoing model auditing
Scalability of human oversight — mitigated by building clinician network capacity ahead of user growth to protect the under-10-minute SLA
Trust erosion from a single incident — mitigated by pre-built incident response and crisis communication protocols
7. Systems Stack (RevOps / IT Architecture)
Conversational AI: Anthropic Claude API / OpenAI API, Rasa, Dialogflow CX — front-end user experience, removes wait-time barrier
Risk detection: AWS Comprehend Medical, custom ML risk-scoring model, PagerDuty/OpsGenie — safety layer, real-time escalation triggers
Compliance and security: AWS HealthLake, Okta/Auth0, OneTrust — regulatory readiness (HIPAA/GDPR), partner trust
Clinical coordination: Calendly/Acuity, Zendesk/Salesforce Health Cloud, Teladoc Health API — human-in-the-loop escalation and case management
Analytics and monitoring: Mixpanel/Amplitude, Grafana + Prometheus, Weights & Biases/MLflow — engagement tracking, SLA monitoring, model performance

Ops logic: each layer maps directly to one of the four brand promises — immediate, safe, clinically supported, trusted. The analytics layer closes the loop, feeding usage and outcome data back into both product decisions and model retraining.

8. Roadmap

Short term:

Structured pilot with a university partner (controlled user base, clean data collection)
Stand up a clinical advisory board (bias governance, escalation protocol sign-off)
Build the on-call licensed professional network
Publish clear AI-capability documentation (what it does / doesn't do)
Secure HIPAA/GDPR certifications

Long term:

Partnerships with national healthcare systems and insurers
Expand clinical scope to broader mild-to-moderate symptom support
Employer/HR benefit partnerships
New market expansion into underserved regions (e.g., Sub-Saharan Africa, South Asia)
9. Why This Is an Innovative Model (Not Just an App)

Most competitors optimize for one variable — scale (AI-only) or credibility (human-only). This model treats trust as the growth lever: it monetizes accessibility (freemium) while using structured human escalation as the differentiator that unlocks the hesitant, underserved segment neither incumbent captures. The operating model, revenue model, and analytics framework are built around the same north star metric — engagement with safety — rather than engagement alone.

Repository Contents
Business_Innovation_Summative_1_-Business_Report-_Smolgovsky_pdf.pdf — full business innovation report (exploration, innovation, validation, impact, risk, tech stack, conclusions)
